F 0578
Level of Harm - Minimal harm
or potential for actual harm
Honor the resident's right to request, refuse, and/or discontinue treatment, to participate in or refuse to
participate in experimental research, and to formulate an advance directive.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 2. R185's
Census (6/23/23) documents R185 was admitted to the facility 6/8/23.
Residents Affected - Few
R185's Electronic Medical Record, in it's entirety as available at the time of review (6/20/23 at 3:46 pm), did
not document any code status to direct staff what actions to take in a life saving situation involving R185.
On 6/21/23 at 11:26 am, R185 stated, I have talked about this (life saving measures) with my kids. At my
stage of life I would want them to try (to resuscitate) a little bit but I wouldn't want them to keep dragging it
out for a long time.
R185's Minimum Data Set, dated [DATE] documents R185 received a score of 14 out of a possible 15
during a Brief Interview for Mental Status (BIMS), rating R185 as cognitively intact.
Based on interview and record review the facility failed to honor resident's right to choose to receive or
decline treatments including life saving interventions by failing to incorporate the resident's choices
regarding cardiopulmonary resuscitation into their medical record and plan of care according to the facility
policy. This failure affects two of two residents (R85, R185) reviewed for advanced directives on the sample
list of 31.
Findings include:
The facility policy Advance Directives, admission Policy dated July 2022 documents the following: (The
facility) recognizes an individual's right to formulate an advance directive and will use its best effort to
inform its residents of this right.
Procedure:
Upon admission, the resident (or the appropriate surrogate decision maker as outlined by the Health Care
Surrogate Act or Powers-of-Attorney, if resident is mentally incapacitated) will be given an informational
packet which explains advance directives and the resident's right to formulate same. Social Service / Nurse
will request at the time of admission whether or not the resident has executed an advance directive.
1. R85's Physician Order Summary Sheet dated June 2023 documents the following diagnoses: Chronic
Kidney Disease Stage IV and Intra-Abdominal Lymph Nodes- Diffuse Large B-Cell Lymphoma. The same
POS does not document Advance Directives/Code Status.
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 11
Event ID:
145400
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145400
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
06/23/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Westminster Village
2025 East Lincoln Street
Bloomington, IL 61701
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0578
Level of Harm - Minimal harm
or potential for actual harm
R85's Electronic Medical Record (EMR) did not document R85's desire to have or not to have life savings
interventions. Advance Directives were not documented in R85's electronic medical record.
R85's Care Plan dated 6/14/23 documents R85 was admitted to the facility on [DATE] but does not
document any Advance Directives/Code Status.
Residents Affected - Few
On 6/20/23 at 1:20 PM V6 Registered Nurse reviewed R85's Electronic and Paper Medical Record and
confirmed R85 does not have a POLST (Physician Order For Life-Sustaining Treatment) form or Advance
Directive recorded anywhere in her medical record. V6 stated R85 came from Assisted Living (sister facility)
and they may have a copy of R85's Advance Directives/Code Status but it is not currently in her chart. V6
stated the facility considers everyone a full code until the POLST is filled out and signed by the physician.
On 6/20/23 at 1:45 PM V1 Administrator confirmed R85's Advance Directives/Code Status should be
recorded in her medical record, there should be a physician order for code status, and it should also be on
R85's Care Plan. V1 stated R85 was admitted from Assisted Living (sister facility) and usually the Advance
Directive/Code Status is obtained from there upon admission however this time it was not. R85's POLST
form was requested but never brought into the facility and therefore not recorded in R85's medical record.
V1 stated the facility would obtain a copy and have a physician review it and get it in R85's medical record.
On 6/20/23 at 2:58 PM V1 Administrator provided a copy of R85's POLST form. R85's POLST form
documents V10 (R85's Power of Attorney), on behalf of R85, declined life saving interventions and chose
selective treatment only. R85's POLST form is dated 6/20/23 and signed by V11 Nurse Practitioner.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145400
If continuation sheet
Page 2 of 11
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145400
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
06/23/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Westminster Village
2025 East Lincoln Street
Bloomington, IL 61701
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0607
Develop and implement policies and procedures to prevent abuse, neglect, and theft.
Level of Harm - Potential for
minimal harm
Based on interview and record review, the facility failed to develop their abuse prevention policy to include
the required 2 hour time frame for reporting allegations of abuse the state survey agency (Illinois
Department of Public Health). This failure has the potential to affect all 36 residents residing on the certified
parts of the facility.
Residents Affected - Many
Findings include:
The facility policy Abuse Policy - (Facility Name) dated June 2023 documents, This facility will immediately
(within 24 hours) report such instance, suspicion, or allegation of abuse, neglect, mistreatment,
misappropriation of property, or injury of unknown source to the Illinois Department of Public Health. This
statement is repeated Upon receiving a report of an instance, suspicion, or allegation of abuse, neglect,
mistreatment, misappropriation of property, and injuries of an unknown source concerning a resident of
(Facility Name), the Administrator or Director of Nursing will submit a facility incident report to IDPH (Illinois
Department of Public Health) not more than 24 hours after receiving the report. This same policy did not
document the required prohibition of abuse through the use of technology, such as audio and video
recording of residents.
On 6/22/23 at 1:38 pm, V1, Administrator, confirmed the facility's abuse policy directed that allegations of
abuse be reported to IDPH within 24 hours. V1 then stated she was not aware that the requirement for
reporting abuse allegations to IDPH was 2 hours.
The facility's Resident Census and Conditions of Residents dated 6/23/23 documents 36 residents reside in
the certified parts of the facility.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145400
If continuation sheet
Page 3 of 11
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145400
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
06/23/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Westminster Village
2025 East Lincoln Street
Bloomington, IL 61701
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0695
Provide safe and appropriate respiratory care for a resident when needed.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 3. On 6/21/23
at 10:40 AM R24 was wearing her oxygen per nasal cannula. The tubing and humidifier bottle were not
dated or initialed for last date changed.
Residents Affected - Some
On 6/21/23 at 1:30 PM V3 Assistant Director of Nurses (ADON) stated oxygen tubing and humidifier bottles
should be changed weekly on Sundays. V3 confirmed this has not been a physician order and has not been
documented on the resident's Treatment Administration Record up until now and it should have been. V3
confirmed the nurses should also be dating and initialing the tubing and humidifier bottle when changing
them. V3 confirmed this is a standard of practice that should be followed when administering oxygen. V3
stated the facility added the order to change oxygen tubing and humidifier bottles to the POS and TAR
today (6/21/23) for all resident's currently receiving oxygen therapy.
R24's Physician Order Sheet (POS) dated June 2023 documents R24 is diagnosed with Acute on Chronic
Combined Systolic (Congestive) and Diastolic (Congestive) Heart Failure and is currently on Hospice Care.
The same POS documents an order for Oxygen at two - ten liters per minute via nasal cannula as needed
for Dyspnea. The same POS does not document an order to change oxygen tubing or humidifier bottles.
R24's Care Plan dated 4/26/23 documents R24 is on Oxygen therapy due to Congestive Heart Failure and
the staff are to provide oxygen as ordered by the physician and change oxygen tubing and humidifier bottle
weekly.
R24's Treatment Administration Record (TAR) dated June 2023 documents the order to change oxygen
tubing and humidifier bottle was added on 6/21/23 and not completed before this date.
4. On 6/21/23 at 10:10 AM R21's Continuous Positive Airway Pressure (CPap) mask was laying on her
bedside table. The mask appeared dirty and had debris on the soft plastic that touches the resident's face
and mouth. It did not appear to have been cleaned recently.
On 6/21/23 at 1:30 PM V3 ADON stated CPap masks and tubing should be cleaned daily. V3 confirmed this
is a standard of practice that should be followed when caring for a CPap machine. V3 stated the order to
wash the CPap mask was added to R21's Physician Orders as of today (6/21/23).
R21's Physician Order Sheet (POS) dated June 2023 documents R21 was admitted on [DATE], is
diagnosed with Obstructive Sleep Apnea, and is to use a CPap machine when sleeping. The same POS
documents on 6/21/23 an order was added to wash R21's CPap mask daily with soapy water and air dry.
R21's Treatment Administration Record (TAR) dated June 2023 documents the order to wash the CPap
mask was added on 6/21/23 and not completed before this date.
R21's Care Plan dated 6/21/23 documents R21 has a history of oxygen saturation drops due to Obstructive
Sleep Apnea and uses a CPap machine. The CPap mask should be cleaned daily with soapy water.
The facility's CPap Cleaning Policy dated 5/15/22 documents CPap machines are ordered by the physician
and used by individual residents to aid in sleep disorders. Staff are responsible for the cleaning and
maintenance of the machine unless otherwise directed. Daily Cleaning includes placing the tubing, the
nasal or face mask and headgear (if appropriate) into a sink with warm, soapy water.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145400
If continuation sheet
Page 4 of 11
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145400
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
06/23/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Westminster Village
2025 East Lincoln Street
Bloomington, IL 61701
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0695
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Agitate in the water for approximately five minutes, rinse well with warm water and allow to dry until all
moisture is gone. This should be done every morning.
Based on observation, interview, and record review, the facility failed to maintain respiratory equipment in a
sanitary manner according to facility policy, and failed to follow facility policy for documenting maintenance
of respiratory equipment. This failure affects four residents (R7, R10, R21, and R24) out of four reviewed for
respiratory care on the sample list of 31.
Findings include:
1. On 6/20/23 at 10:36 am, R10 was seated in a cushioned chair in R10's own room. R10's oxygen
concentrator was operating at 2.5 liters per minute. R10 was receiving oxygen therapy through nasal
cannula prongs inserted directly into R10's nostrils. The nasal cannula tubing and humidifier bottle were not
dated to indicate the most recent changing of the tubing and humidifier bottle, and there was no receptacle
to contain the nasal cannula tubing when not in use. There was a nebulizer machine on the bedside bureau
in R10's room with oxygen tubing attached and the tubing for the nebulizer was likewise undated to indicate
when the most recent changing of the tubing was.
R10's current Physician Order Sheet (6/21/23) did not document any instructions for changing R10's nasal
cannula tubing nor humidifier bottle.
R10's Treatment Administration Record (TAR) dated for June 2023 did not document any instructions for
the changing of R10's nasal cannula tubing, humidifier bottle, nor nebulizer tubing. This TAR did not
document any changes of R10's tubings nor humidifier bottle.
2. On 6/20/23 at 10:40 am, 1:07 pm, and 6/21/23 at 12:40 pm, R7 was laying in bed in R7's own room with
an oxygen concentrator operating at 2 liters per minute. The nasal cannula prongs were directly in R7's
nostrils as R7 was receiving oxygen therapy at the time of observations. R7's nasal cannula tubing and
humidifier bottle were not dated to indicate the most recent changing of the tubing and humidifier bottle.
There was not any kind of receptacle to store the tubing in when not in use.
R7's current Physician Order Sheet (6/22/23) documents to Change oxygen humidifier and tubing every
week, night shift every Wednesday.
The facility policy Oxygen Therapy dated 9/10/22 documents, Oxygen tubing will be changed and filter
cleaned weekly. The tubing will be stored in a bag or other containment so it does not lie on the floor, along
with a date as to when the tubing was changed. The humidifier bottle will be replaced weekly and/ or when
empty and dated, documented on weekly oxygen housekeeping list.
On 6/21/23 at 10:49 am, V3, Assistant Director of Nursing, stated, The 'weekly oxygen housekeeping list' is
the TAR (Treatment Administration Record). V3 continued to state, The nurses did not follow the policy for
dating the tubings and humidifier bottles, and they should have been documenting the changes on the TAR.
The facility routine is to change the tubings and bottles on Sunday nights and it is just one of those things
we do and forget about documenting.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145400
If continuation sheet
Page 5 of 11
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145400
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
06/23/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Westminster Village
2025 East Lincoln Street
Bloomington, IL 61701
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0757
Ensure each resident’s drug regimen must be free from unnecessary drugs.
Level of Harm - Minimal harm
or potential for actual harm
Based on interview and record review the facility failed to review resident's medication orders to prevent
duplicate therapy and the potential for excess dosage for four of four residents (R135, R5, R13, R136)
reviewed for duplicate medications in the sample list of 31.
Residents Affected - Some
Findings include:
The facility's admission Medication Regimen Review with a Revision date of 10/1/18 documents, An
electronic medication regimen review (MRR) will be performed within 72 hours or an agreed upon
timeframe of admission by a licensed pharmacist per written authorization from the facility. Significant
medications issues identified by the consultant pharmacist during the admission Medication Regimen
Review, must be communicated to the prescriber or designee and resolved by 11:59 P.M. the following day,
per the IMPACT Act. Procedure 1. The consultant pharmacist will routinely access an electronic file to
identify new admissions. 2. The consultant pharmacist will conduct an electronic comprehensive review of
each patient's medication therapy. 7. The pharmacist's analysis of the medication regimen includes: 7.2
Review of appropriate dose with special consideration of age, disease state, pharmacodynamics and
pharmacokinetics.
The 2021-2022 Lexicomp Drug Reference Handbook documents, Safety: Acetaminophen-induced
hepatotoxicity, which can be life threatening, has been associated with doses greater than 4 grams a day.
1.) R135's Order Summary Report dated 6/21/23 documents a diagnosis of acute Kidney Failure. This
Order Summary documents orders for Acetaminophen Suppository Insert 650 mg (milligrams) rectally
every 4 hours as needed for Pain or elevated temperature with a start date of 6/2/23. This has a potential
total of 3,900 mg. This Order Summary documents an order for Tylenol Oral Tablet (Acetaminophen) Give
1500 mg by mouth every 12 hours as needed for Pain with a start date of 6/6/23. This has a potential total
of 3,000 mg. This Order Summary documents an order for Tylenol Tablet 325 MG (Acetaminophen) Give 2
tablets by mouth every 4 hours as needed for Pain or elevated temperature with a start date of 6/2/23. This
has a potential total of 3,900 mg.
The above prescribed Tylenol/Acetaminophen has the potential to exceed the maximum daily dose of 4
grams. The potential total dosage in 24 hours adds up to 10,800 mg (10.8 grams).
2.) R5's Order Summary Report dated 6/21/23 documents diagnoses including Pulmonary Hypertension
and Transient Cerebral Ischemic Attack. This Order Summary documents orders for Acetaminophen
Suppository Insert 650 mg rectally every 4 hours as needed for Pain or elevated temperature with a start
date of 11/27/22. This has a potential total of 3,900 mg. This Order Summary documents an order for Norco
Oral Tablet 5-325 MG (Hydrocodone-Acetaminophen) Give 1 tablet by mouth every 8 hours as needed for
Moderate/severe pain with a start date of 1/30/23. This has a potential total of 975 mg. This Order Summary
has an order for Tylenol Oral Tablet 325 MG (Acetaminophen) Give 650 mg by mouth three times a day for
pain with a start dated of 3/31/23. This has a potential total of 1,950 mg. This Order Summary has an order
for Tylenol Tablet 325 MG (Acetaminophen) Give 2 tablets by mouth every 4 hours as needed for Pain with
a start date of 12/14/22. This has a potential total of 3,900 mg.
The above prescribed Tylenol/Acetaminophen/Norco has the potential to exceed the maximum daily dose
of 4 grams. The potential total dosage in 24 hours adds up to 10,725 mg (10.725 grams).
3.) R13's Order Summary Report dated 6/21/23 documents diagnoses including Metabolic Encephalopathy
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145400
If continuation sheet
Page 6 of 11
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145400
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
06/23/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Westminster Village
2025 East Lincoln Street
Bloomington, IL 61701
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0757
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
and Acute Kidney Failure. This Order Summary documents an order for Acetaminophen Suppository Insert
650 mg rectally every 4 hours as needed for Pain or elevated temperature with a start date of 10/6/22. This
has a potential total of 3,900 mg. This Order Summary documents an order for Acetaminophen Tablet Give
500 mg by mouth every 6 hours as needed for pain with a start date of 10/7/22. This has a potential total of
2,000 mg. This Order Summary documents an order for Tylenol Tablet 325 MG (Acetaminophen) Give 2
tablets by mouth every 4 hours as needed for Pain or elevated temperature with a start date of 10/6/22. This
has a potential total of 3,900 mg.
The above prescribed Tylenol/Acetaminophen has the potential to exceed the maximum daily dose of 4
grams. The potential total dosage in 24 hours adds up to 9,800 mg (9.8 grams).
4.) R136's Order Summary Report dated 6/21/23 documents diagnoses including Cystitis and
Hypertension. This Order Summary documents an order for Acetaminophen Oral Tablet 500 mg
(Acetaminophen) Give 2 tablets by mouth two times a day with a start date of 6/12/23. This has a potential
total of 2,000 mg. This Order Summary documents an order for Acetaminophen Suppository Insert 650 mg
rectally every 4 hours as needed for Pain or elevated temperature with a start date of 6/12/23. This has a
potential total of 3,900 mg. This Order Summary documents an order for Tylenol Tablet 325 MG
(Acetaminophen) Give 2 tablets by mouth every 4 hours as needed for Pain or elevated temperature with a
start date of 6/12/23. This has a potential total of 3,900 mg.
The above prescribed Tylenol/Acetaminophen has the potential to exceed the maximum daily dose of 4
grams. The potential total dosage in 24 hours adds up to 9,800 mg (9.8 grams).
On 6/22/23 at 1:38 PM, V3 Assistant Director of Nursing stated regarding the Tylenol that the pharmacist
reviews the medication records but not sure if they review for duplicate Tylenol therapy. V3 confirmed if the
Tylenol are separate orders in the computer that there is nothing to stop them from giving too much Tylenol.
V3 stated that it is probably a mixture between what they come back from the hospital with and the facility's
standing orders.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145400
If continuation sheet
Page 7 of 11
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145400
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
06/23/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Westminster Village
2025 East Lincoln Street
Bloomington, IL 61701
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted
professional principles; and all drugs and biologicals must be stored in locked compartments, separately
locked, compartments for controlled drugs.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observation, interview and record review the facility failed to document an open date on insulin when
opened and failed to secure a controlled substance in a medication refrigerator for four of four residents
(R15, R137, R21, R87) reviewed for medication storage and labeling in the sample list of 31.
Findings include:
The facility's Storage and Expiration Dating of Medications, Biologicals policy with a revision dated of
7/21/22 documents, 5. Once any medication or biological package is opened, Facility should follow
manufacturer/supplier guidelines with respect to expiration dates for opened medications. Facility staff
should record the date opened on the primary medication container (vial, bottle, inhaler) when the
medication has shortened expiration date once opened or opened. 5.3 If a multi-dose vial of an injectable
medication has been opened or accessed (e.g. {example} needle-punctured), the vial should be dated and
discarded within 28 days unless the manufacturer specifies a different (shorter or longer) date for that
opened vial.
The facility's Storage and Expiration Dating of Medications, Biologicals policy with a revision date of 7/21/22
documents, 12. Controlled Substances Storage: 12.1 Facility should ensure that Schedule II - V controlled
substances are only accessible to licensed nursing, Pharmacy, and medical personnel designated by
Facility. 12.2 After receiving controlled substances and adding to inventory, Facility should ensure that
Schedule II-V controlled substances are immediately placed into a secured storage area (i.e. {for example},
a safe, self-locked cabinet, or locked room, in all cases in accordance with Applicable Law). 12. 3 Facility
should ensure that all controlled substances are stored in a manner that maintains their integrity and
security. 12.4 Controlled Substances stored in the refrigerator must be in a separate container and double
locked.
1.) R15's Order Summary Report dated 6/22/23 documents a diagnosis of Type 2 Diabetes Mellitus with
Diabetic Chronic Kidney Disease and has order for Humalog KwikPen Subcutaneous Solution Pen injector
Inject as per sliding scale with a start date of 4/8/23. This Order Summary documents an order for
HumuLIN 70/30 KwikPen Subcutaneous Suspension Pen-injector (70-30) 100 unit/ml (milliliter) inject 18
units subcutaneously one time a day with a start date of 6/7/23.
On 6/22/23 at 8:35 AM, V6 Registered Nurse completed a medication cart review. R15's HumuLIN 70/30
(insulin) vial with approximately 1/4 of the vial remaining was not dated with an open date. R15's Humalog
Kwik Pen (insulin) was not dated with an open date and had been used. R15's Humilin 70/30 Kwik Pen
injector was not labeled with an open date and had been used.
2.) R137's Order Summary Report dated 6/22/23 documents a diagnosis of Type 2 Diabetes with an order
for Insulin Lispro 100 unit/ml (milliliters), Inject 10
units subcutaneously three times a day with a start date of 6/14/23.
On 6/22/23 at 8:35 AM, V6 completed a medication cart review. R137's Insulin Lispro 100 unit/ml did not
have an open date documented on the insulin vial.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145400
If continuation sheet
Page 8 of 11
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145400
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
06/23/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Westminster Village
2025 East Lincoln Street
Bloomington, IL 61701
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Some
3.) R21's Order Summary Report dated 6/22/23 documents a diagnosis of Type 2 Diabetes Mellitus with an
order for Insulin Deglu[DATE] unit/ml, inject 60 units subcutaneously one time a day with a start date of
6/14/23.
On 6/22/23 at 8:35 AM, V6 completed a medication cart review. R21's Insulin Deglu[DATE] unit/ml injector
pen was not labeled with an open date. V6 confirmed there was no open date labeled on R15, R137 and
R21's insulin.
4.) R87's Order Summary Report dated 6/22/23 documents diagnoses including Chronic Obstructive
Pulmonary Disease and Alzheimer's Disease with an order for Morphine Sulfate (Concentrate) Oral
Solution 20 mg (milligrams)/ml (milliliters) give 0.25 ml by mouth every two hours as needed for
moderate/severe pain or shortness of breath with a start date of 6/5/23.
On 6/22/23 at 8:35 AM, V6 completed a medication room review. The medication refrigerator was not
locked and the drawer inside the refrigerator that had a lock on it was not locked. V6 opened the drawer and
was unaware that there was medication inside the drawer. V6 confirmed R87's Morphine was inside the
unlocked drawer. V6 took the Morphine and stated that V6 would get it logged into the narcotic count book.
On 6/22/23 at 1:38 PM, V3 Assistant Director of Nursing stated that insulin should be dated as soon as it is
opened and confirmed that R87's Morphine should have been locked in the refrigerator.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145400
If continuation sheet
Page 9 of 11
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145400
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
06/23/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Westminster Village
2025 East Lincoln Street
Bloomington, IL 61701
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0880
Provide and implement an infection prevention and control program.
Level of Harm - Minimal harm
or potential for actual harm
Failures at this level required more than one deficient practice statement.
Residents Affected - Many
A. Based on observation, interview, and record review, the facility failed to implement infection control
measures to protect oxygen tubing from cross contamination for a resident isolated with a drug resistant
infection. This failure affects one resident (R10) out of four reviewed for respiratory care on the sample list
of 31.
B. Based on interview and record review, the facility failed to develop a water management plan that
included the required risk assessment, control measures, and testing protocols to reduce the risk of growth
of Legionella and other pathogens in the facility's water system. This failure has the potential to affect all 36
residents in the facility.
Findings include:
a. On 6/20/23 at 10:36 am, there were posted signs on R10's room door to indicate R10 was being isolated
with contact precautions requiring gown and gloves to be worn in the room. R10 was seated in a cushioned
chair in R10's own room. R10's oxygen concentrator was operating at 2.5 liters per minute. R10 was
receiving oxygen therapy through nasal cannula prongs inserted directly into R10's nostrils. There was no
receptacle to contain the nasal cannula tubing when not in use. The nasal cannula tubing was not dated to
indicate when the most recent change of tubing had been.
R10's current Physician Order Sheet (6/22/23) documents, Maintain contact isolation due to multi-drug
resistant organism in urine, dated as initiated 6/19/23.
On 6/20/23 at 2:50 pm, V9, Registered Nurse, stated, (R10) is in isolation for MRSA (Methicillin Resistant
Staphylococcus Aureus) in the urine, to be safe we gown and glove to go in the room.
On 6/20/23 at 2:53 pm, R10 was laying in bed and the nasal cannula tubing was laying on the floor
between R10's chair and the oxygen concentrator so that the nasal prongs were in direct contact with the
carpeted floor. There was not any kind of receptacle present to contain the nasal cannula while not in use.
On 6/21/23 at 10:13 am, R10 was in bed in R10's own room, laying supine, with the head of the bed
elevated. R10 was receiving oxygen therapy with the nasal cannula prongs directly in R10's nostrils. R10's
nasal cannula tubing was not dated to indicate the tubing had been changed from the point when the tubing
was laying on the floor.
R10's current Physician Order Sheet (6/21/23) did not document any instructions for changing R10's nasal
cannula tubing.
R10's Treatment Administration Record (TAR) dated for June 2023 did not document any changes of R10's
nasal cannula tubing.
On 6/21/23 at 10:49 am, V3, Assistant Director of Nursing, stated that the tubing being left on the floor, and
then (R10) using the tubing, was very much so a concern.
The facility policy Oxygen Therapy dated 9/10/22 documents, The tubing will be stored in a bag or
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145400
If continuation sheet
Page 10 of 11
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
145400
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
06/23/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Westminster Village
2025 East Lincoln Street
Bloomington, IL 61701
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0880
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Many
other containment so it does not lie on the floor, along with a date as to when the tubing was changed. The
humidifier bottle will be replaced weekly and/ or when empty and dated, documented on weekly oxygen
housekeeping list.
On 6/21/23 at 10:49 am, V3, Assistant Director of Nursing, stated, The 'weekly oxygen housekeeping list' is
the TAR (Treatment Administration Record).
b. The facility water management plan (8/2022) fails to fully document the required facility water system risk
assessment where Legionella and other pathogens could grow and spread in the facility water system. The
same record did not document the required consideration of the ASHRAE (American Society of Heating,
Refrigerating and Air-Conditioning Engineers) standard or the (CDC) Centers for Disease Control and
Prevention Water Management Program toolkit. The plan did not identify any specific testing protocols,
acceptable ranges for control measures, or any corrective actions when control limits are not maintained to
reduce the risk of waterborne pathogens in the facility water system.
On 6/23/2023 at 10:30AM, V12 (Director of Facilities and Property) reported not being aware if the facility
completed a comprehensive water system risk assessment for waterborne infections and reported the
facility was not testing water for the presence of waterborne pathogens. V12 was not aware of any
additional policy to the one above.
The Resident Census and Conditions of Residents report (6/23/2023) documents 36 residents reside in the
facility.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
145400
If continuation sheet
Page 11 of 11